The long term objective of this research is to better understand at a molecular level how opioids, specifically opioid peptides, interact with opioid receptors. A second objective is to identify peptide-based affinity labels for opioid receptors. These affinity labels which bind covalently to their targets, can be used as pharmacological tools in a variety of studies of opioid receptor structure and function. A better understanding at a molecular level of how opioids interact with their receptors could provide invaluable information for the design of new analgesics with less of the side effects (addiction liability, etc.) associated with the currently used narcotics. The proposed research involves two phases.
The specific aims of the first phase of this research are to prepare a variety of peptide-based potential affinity labels for opioid receptors and to evaluate their ability to interact with receptors in an irreversible manner. The proposed derivatives include peptides with selectivity for each of the opioid receptor types; reactive functionalities will be incorporated at different positions in these peptides. Depending upon the peptides these analogues will be prepared either in solution or by solid phase peptide synthesis. Receptor affinity will be determined in radioligand binding assays using cloned opioid receptors, and the peptides ability to inhibit radioligand binding in a wash-resistant manner determined in these assays. Compounds exhibiting wash-resistant inhibition of binding to receptors will be chosen for further study in the second phase of the research. They will be examined against chimeric receptors to assess which regions of the receptors may be required for irreversible binding of the peptides. The selected peptides will be prepared in labeled form for further study of affinity labeled receptors and a biotin functionality will be attached to these peptides to facilitate receptor isolation. Following isolation the affinity labeled receptors will be subjected to proteolytic digestion and the resulting fragments analyzed by ion spray mass spectrometry to examine the point of attachment of the affinity label.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA010035-04
Application #
2897991
Study Section
Human Development Research Subcommittee (NIDA)
Project Start
1996-09-01
Project End
2001-07-31
Budget Start
1999-08-01
Budget End
2001-07-31
Support Year
4
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Maryland Baltimore
Department
Other Health Professions
Type
Schools of Pharmacy
DUNS #
003255213
City
Baltimore
State
MD
Country
United States
Zip Code
21201
Sinha, Bhaswati; Cao, Zhengyu; Murray, Thomas F et al. (2009) Discovery of dermorphin-based affinity labels with subnanomolar affinity for mu opioid receptors. J Med Chem 52:7372-5
Dattachowdhury, Bhaswati; Murray, Thomas F; Aldrich, Jane V (2009) The synthesis of DAMGO-based potential affinity labels with high mu opioid receptor affinity and the formation of cyclic O-alkyl thiocarbamates. Adv Exp Med Biol 611:265-6
Aldrich, Jane V; Kumar, Vivek; Murray, Thomas F et al. (2009) Dual labeled peptides as tools to study receptors: nanomolar affinity derivatives of TIPP (Tyr-Tic-Phe-Phe) containing an affinity label and biotin as probes of delta opioid receptors. Bioconjug Chem 20:201-4
Aldrich, Jane V; Kumar, Vivek; Dattachowdhury, Bhaswati et al. (2008) Solid Phase Synthesis and Application of Labeled Peptide Derivatives: Probes of Receptor-Opioid Peptide Interactions. Int J Pept Res Ther 14:315-321
Aldrich, J V; Choi, H; Murray, T F (2004) An affinity label for delta-opioid receptors derived from [D-Ala2]deltorphin I. J Pept Res 63:108-15
Choi, H; Murray, T F; Aldrich, J V (2003) Synthesis and evaluation of potential affinity labels derived from endomorphin-2. J Pept Res 61:58-62
Kumar, Vivek; Aldrich, Jane V (2003) A solid-phase synthetic strategy for labeled peptides: synthesis of a biotinylated derivative of the delta opioid receptor antagonist TIPP (Tyr-Tic-Phe-Phe-OH). Org Lett 5:613-6
Choi, Heekyung; Murray, Thomas F; Aldrich, Jane V (2003) Synthesis and evaluation of derivatives of leucine enkephalin as potential affinity labels for delta opioid receptors. Biopolymers 71:552-7
Choi, H; Murray, T F; Aldrich, J V (2003) Dermorphin-based potential affinity labels for mu-opioid receptors. J Pept Res 61:40-5
Kumar, Vivek; Murray, Thomas F; Aldrich, Jane V (2002) Solid phase synthesis and evaluation of Tyr-Tic-Phe-Phe(p-NHCOCH(2)Br) ([Phe(p-bromoacetamide)(4)]TIPP), a potent affinity label for delta opioid receptors. J Med Chem 45:3820-3

Showing the most recent 10 out of 14 publications